Hepatitis C News

• Patients Cured of HCV Still at High Liver Cancer Risk The burden of hepatocellular carcinoma (HCC) appears likely to move from patients who currently have hepatitis C virus (HCV) infection to those who have previously been cured, a new modeling study suggests.
  Reuters Health Information, November 25, 2020
• Combo DAA May Benefit Patients With Resistant HCV Genotype 3 A meta-analysis of 34 research reports found that direct-acting antiviral (DAA) combo treatment can be effective in achieving sustained virologic response in patients with HCV genotype 3.
  Medscape Medical News, November 23, 2020
• Opt-Out Policy Increased HIV/HCV Testing Bundled opt-out HIV/hepatitis C virus (HCV) testing increased the percentage of syringe service program (SSP) clients who received HIV and HCV rapid tests at enrollment into the program.
  Medscape Medical News, November 19, 2020
• ANAC 2020 HCV Care Can Learn a Thing or Two From the HIV Experience Patients with hepatitis C virus and HIV share some of the same treatment challenges, suggesting similar care models can be used for these conditions to improve rates of treatment adherence and success.
  Medscape Medical News, November 14, 2020
• COVID-19 Linked to Increased Risk for Parkinson's One of the neurologic complications of COVID-19 may be the development of Parkinson's disease, a new report suggests.
  Medscape Medical News, November 05, 2020
• Health Care Groups Dive Into Property Tax Ballot Fight They see Proposition 15 as a potential savior for chronically underfunded local health departments struggling to respond to the worst public health crisis in more than a century.
  Kaiser Health News, October 20, 2020
• Alert Trio Awarded Nobel Prize in Medicine for Discovering Hep C Virus The achievement by two Americans and a British-born scientist rapidly led to medications, blood tests, a cure, and 'hopes of eradicating hepatitis C virus from the world population.'
  Medscape Medical News, October 05, 2020
• Why Are So Few Drugs Tested for Safety in Pregnancy? Expectant mothers have long been excluded from clinical trials. Some experts say this practice needs to change.
  Undark, October 01, 2020
• Cornea Donation Restrictions Outdated, Harmful, Study Suggests The length of the bans on donations ― 5 years in the United States and 1 year in Canada ― are unnecessary because of improvements in HIV testing, authors say.
  Medscape Medical News, October 01, 2020
• Hepatocellular Carcinoma Shows Risk Factor Shift The most common form of liver cancer has seen a demographic shift, with incidence highest in the Hispanic population. The good news in HCC is that rates appear to be declining among young men.
  Medscape Medical News, September 25, 2020
• HCV-Related Liver Cancer Incidence Dropped in US Cohort The incidence of hepatocellular carcinoma declined after widespread use of direct-acting antiviral therapies to treat hepatitis C, according to findings from a large population-based study.
  Medscape Medical News, September 16, 2020
• HCV-Infected Kidneys Safe to Transplant With Antiviral Treatment HCV-infected donor kidneys are safe to transplant provided recipients are treated immediately with antiviral agents for 8 weeks.
  Medscape Medical News, September 09, 2020
• ILC 2020 Many Advanced Countries Missing Targets for HCV Elimination The World Health Organization wants to eliminate hepatitis C infection by the end of the decade. Researchers performed disease progression models of HCV infection in 45 high-income countries.
  Medscape Medical News, September 04, 2020
• Hepatitis C Drugs Show Promise Against the Coronavirus Antiviral drugs developed to the treat hepatitis C virus (HCV) infection may also be effective against the new coronavirus, a new report suggests.
  Reuters Health Information, September 02, 2020
• Antiviral Combo Shows Early Promise Against HCV in Pregnancy The combination of ledipasvir and sofosbuvir appears to be safe and effective in treating pregnant women infected with genotype 1 hepatitis C virus, curing all nine participants in a phase 1 trial.
  Reuters Health Information, August 06, 2020
• New CDC Guidance for Healthcare Personnel Exposed to HCV New recommendations from the CDC offer guidance for postexposure testing and clinical management of healthcare personnel exposed to hepatitis C virus.
  Medscape Medical News, July 23, 2020
• HIV Infection May Impact Sensitivity of Rapid Diagnostic Tests for HCV Hepatitis C virus rapid diagnostic tests had variable sensitivity in patients with HIV, in a multinational retrospective study.
  Reuters Health Information, July 13, 2020
• COVID-19 Update: Shelter-in-Place, Hyperglycemia Predicts Death The coronavirus stories Medscape's editors around the globe think you need to know about today.
  Medscape Medical News, July 13, 2020
• COVID 2020 Hep C Sofosbuvir/Daclatasvir Combo Promising for COVID-19 Data are preliminary, but early evidence shows that the combination of two direct-acting antivirals can speed time to recovery in patients hospitalized with COVID-19.
  Medscape Medical News, July 13, 2020
• Analysis: How A COVID-19 Vaccine Could Cost Americans Dearly The United States is the only developed nation unable to balance cost, efficacy and social good in setting prices.
  Kaiser Health News, July 08, 2020